Michelle Everill is a visionary leader at the intersection of clinical research, behavioral science, and organizational transformation. With more than 20 years of experience across the life sciences industry, she has held senior roles in clinical operations, data analytics, and trial optimization at leading organizations including Alnylam Pharmaceuticals, Bristol Myers Squibb, Johnson & Johnson, and Pfizer.

Michelle’s work focuses on improving clinical trial performance, enhancing patient engagement, and leveraging data and technology to drive more efficient and equitable research. In addition to her industry leadership, she is the founder of a coaching and advisory platform centered on behavioral architecture and leadership development, helping individuals and organizations navigate transformation in the age of AI.